Skip to main content
. 2017 Aug 22;15:156. doi: 10.1186/s12957-017-1229-x

Table 2.

Multivariate analysis of variables predictive for stage B HCC patient survival

Survival p value Risk ratio 95% confidence interval
Albumin (g/dl), <4 vs ≥4 0.0024 1.837 1.241 2.728
Anatomical vs nonanatomical 0.0132 0.509 0.304 0.866
AP-factor, AP2 vs AP3 0.0023 0.416 0.234 0.732
Tumor number, 1 vs 4over 0.0001 0.380 0.229 0.615
     2,3 vs ≥4 0.0011 0.414 0.248 0.699
Microscopic portal vein invasion, vp0 vs vp2 0.0001 0.302 0.174 0.545
     vp1 vs vp2 0.0133 0.435 0.231 0.837

PIVKA-II, protein induced by vitamin K absence or antagonism factor II; AP-factor, a product of the serum levels of AFP and PIVKA-II

vp0: no tumor thrombus in the portal vein

vp1: tumor thrombus distal to the second branches of the portal vein

vp2: tumor thrombus in the second branches of the portal vein